“spinal-muscular-atrophy” Archives

in
Entry Author Date Location
Astellas Reports Third Patient Death in Audentes Gene Therapy Study 08/21/20 San Francisco
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy 08/07/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
Biotech Roundup: GSK’s Ante, Shakeup at Sage, Telehealth’s Rise & More 04/10/20 National
Bio Roundup: Biotech Billions, COVID-19 R&D, Zolgensma’s Path & More 04/03/20 National
A Baby’s Milestones and the Next Steps for Novartis in Gene Therapy 03/31/20 Raleigh Durham
Roche Challenger to Biogen’s SMA Drug Succeeds in Pivotal Study 11/11/19 National
FDA Halts Novartis Gene Therapy Study Amid Animal Safety Concerns 10/30/19 National
Drug Pricing: Innovation, Investment, and the Public Good 09/24/19 Boston
FDA: Despite “Manipulated” Data, $2M Gene Therapy Should Stay on Market 08/06/19 National
Bio Roundup: Leiden’s Exit, Depression Data, a New Pricing Bill & More 07/26/19 National
Bio Roundup: Opioid Exposé, Gilead’s Gambit, Life Science IPOs & More 07/19/19 National
Skyhawk Inks Deal With Genentech for Cancer and Neuro Drug Discovery 07/16/19 Boston
Bio Roundup: Duchenne Race, Warren v. Gottlieb, A $599 Genome & More 07/05/19 National
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits 06/26/19 San Francisco
Bio Roundup: Opioids in Court, IPO Parade, Brain Cancer Bet & More 05/31/19 National
Second US Gene Therapy, Approved for Rare Muscle Disease, to Cost $2M 05/24/19 National
Bio Roundup: Zolgensma Watch, Brain Cancer Blues, Peloton Payout & More 05/24/19 National
Bio Roundup: Rare Disease Showdowns, Prices on TV, Dealmania & More 05/10/19 National
SMA, Migraine Data Lead Neuro Highlights from AAN Meeting 05/07/19 National
Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More 05/03/19 National
SMA Moment: Will Gene Therapy Shift Treatment, Costs of Muscle Disease? 05/02/19 National
Biogen, Taking Its Crisis “Seriously,” Keeps Focus on Neuroscience 04/24/19 Boston
Can We Afford to Be Cured? A Conversation With ICER’s Steve Pearson 04/23/19 Boston
It’s Tough to Find Drugs to Bind to RNA: Arrakis Nabs $75M to Help 04/18/19 Boston
How an Ohio Kids’ Hospital Quietly Became Ground Zero for Gene Therapy 04/15/19 National
Report: Biogen, Novartis Should Drop Prices of Billon-Dollar SMA Drugs 04/04/19 Boston
Dyne Therapeutics Emerges With $50M to Take On Rare Muscle Disease 04/03/19 Boston
Thermo Bags Brammer For $1.7B as Gene Therapy Deal Spree Continues 03/25/19 Boston
Adieu to Adu: Biogen’s Big Alzheimer’s Bet Flops, Shares Routed 03/21/19 Boston
Page 1 of 4 next page »